GBA1 and Parkinson disease: GBA1 mutations were also frequent in under-40 patients (13%), but with a lower percentage than previously shown by Petrucci et al. (20.4% in early onset PD, 14.3% in overall PD population) [13]; this discrepancy possibly being due to differences in geographical recruitment areas and selection criteria for genetic testing.